MedTrace Logo

Using Phenazopyridine for In-office Cystoscopy

NCT02715648 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2020-12-31

No results posted yet for this study

Summary

The investigators propose to conduct a randomized controlled trial to evaluate whether administration of phenazopyridine prior to the procedure decreases office cystoscopy time. Women undergoing in-office cystoscopy at Boston Urogynecology will be recruited.

Conditions

  • Cystoscopy
  • Phenazopyridine

Interventions

DRUG

Phenazopyridine

Sponsors & Collaborators

  • Boston Urogynecology Associates

    lead OTHER

Principal Investigators

  • Eman Elkadry, MD · Practitioner

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02715648 on ClinicalTrials.gov